united healthcare glp 1 coverage Poll: in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Online Weight Loss Covered by

With nearly 2830% weight reduction, retatrutide is no longer just competing with GLP-1 therapies it is challenging the very biology of obesity itself

While semaglutide does not directly increase estrogen, the weight loss it produces can reduce excess aromatase activity and normalize estrogen ratios, particularly in women who are carrying excess visceral fat

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period

Pregnant or breastfeeding individuals, people taking medication, or those with an existing medical condition should consult a healthcare professional before use